All lobbying filings

CONTINENTAL STRATEGY, LLC

CONTINENTAL STRATEGY, LLC filed a Q1 report for DEXCOM on April 18, 2026, reporting $75,000 in lobbying income.

Lobbying for DEXCOM · Healthcare company that develops, manufactures, produces, and distributes CGMs.

All filings by CONTINENTAL STRATEGY, LLC · Everything DEXCOM has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 18, 2026

Income

$75,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

Executive Office of the President (EOP)
Health & Human Services, Dept of (HHS)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

continuous glucose monitoring

Medical/Disease Research/Clinical Labs

continuous glucose monitoring

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.